Data derived from breast cancer and melanoma indicate that fasting cycles combined with chemotherapy can reinforce the T cell-dependent targeted killing of cancer cells both by enhancing the CD8(+)-dependent tumor cytotoxicity and by expanding the Common Lymphoid Progenitors. The gene discussed is CD8A; the disease is breast cancer.